tradingkey.logo

Prenetics Global Ltd

PRE
19.240USD
+1.530+8.64%
Handelsschluss 02/06, 16:00ETKurse um 15 Minuten verzögert
248.08MMarktkapitalisierung
VerlustKGV TTM

Prenetics Global Ltd

19.240
+1.530+8.64%

mehr Informationen über Prenetics Global Ltd Unternehmen

Prenetics Global Ltd is a company principally engaged in the provision of diagnostic and preventive products and services. The Company operates its business through two segments. The Diagnostics segment is mainly engaged in the sale of precision oncology testing services. The Prevention segment is mainly engaged in the design and sale of genetics testing, including update services, and stool-based deoxyribonucleic acid (DNA) tests for early colorectal cancer screening. The Company's products and services include CircleDNA, ACTOnco, ACTHRD and other products. The in-house developed consumer genetic testing product, CircleDNA, offers comprehensive DNA tests capitalizing on in-house developed testing algorithm. ACTOnco is a comprehensive cancer test used to guide treatment selection for major solid tumors. ACTHRD is a test for the homologous recombination deficiency status of cancer patients. The Company is also engaged in consumer health products by a new health and wellness brand IM8.

Prenetics Global Ltd Informationen

BörsenkürzelPRE
Name des UnternehmensPrenetics Global Ltd
IPO-datumJul 06, 2021
CEOKwok (Samantha)
Anzahl der mitarbeiter285
WertpapierartOrdinary Share
GeschäftsjahresendeJul 06
AddresseUnit 703-706, K11 Atelier King's Road, 728 King's Road, Quarry Bay
Stadt
BörseNASDAQ OMX - NASDAQ BASIC
LandHong Kong
Postleitzahl- -
Telefon85222109588
Websitehttps://ir.prenetics.com/
BörsenkürzelPRE
IPO-datumJul 06, 2021
CEOKwok (Samantha)

Führungskräfte von Prenetics Global Ltd

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Sheng Wu (Danny) Yeung
Mr. Sheng Wu (Danny) Yeung
Chairman of the Board, Chief Executive Officer, Co-Founder
Chairman of the Board, Chief Executive Officer, Co-Founder
--
--
Mr. Yin Pan (Ben) Cheng
Mr. Yin Pan (Ben) Cheng
Independent Director
Independent Director
--
--
Ms. Wing Kwan (Winnie) Chiu
Ms. Wing Kwan (Winnie) Chiu
Independent Director
Independent Director
--
--
Dr. Chi Hung (Lawrence) Tzang, Ph.D.
Dr. Chi Hung (Lawrence) Tzang, Ph.D.
Co-Founder, Chief Scientific Officer
Co-Founder, Chief Scientific Officer
--
--
Mr. Hoi Chun (Stephen) Lo
Mr. Hoi Chun (Stephen) Lo
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Senthil Sundaram, M.D.
Dr. Senthil Sundaram, M.D.
Chief Clinical Officer
Chief Clinical Officer
--
--
Dr. Yung Ho (Peter) Wong
Dr. Yung Ho (Peter) Wong
Chief Technology Officer
Chief Technology Officer
--
--
Mr. Joel Neoh
Mr. Joel Neoh
Chief Consumer Officer, Chief Executive Officer of CircleDNA
Chief Consumer Officer, Chief Executive Officer of CircleDNA
--
--
Ms. Kathryn Henry
Ms. Kathryn Henry
Independent Director
Independent Director
--
--
Mr. David Vanderveen
Mr. David Vanderveen
Independent Director
Independent Director
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Sheng Wu (Danny) Yeung
Mr. Sheng Wu (Danny) Yeung
Chairman of the Board, Chief Executive Officer, Co-Founder
Chairman of the Board, Chief Executive Officer, Co-Founder
--
--
Mr. Yin Pan (Ben) Cheng
Mr. Yin Pan (Ben) Cheng
Independent Director
Independent Director
--
--
Ms. Wing Kwan (Winnie) Chiu
Ms. Wing Kwan (Winnie) Chiu
Independent Director
Independent Director
--
--
Dr. Chi Hung (Lawrence) Tzang, Ph.D.
Dr. Chi Hung (Lawrence) Tzang, Ph.D.
Co-Founder, Chief Scientific Officer
Co-Founder, Chief Scientific Officer
--
--
Mr. Hoi Chun (Stephen) Lo
Mr. Hoi Chun (Stephen) Lo
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Senthil Sundaram, M.D.
Dr. Senthil Sundaram, M.D.
Chief Clinical Officer
Chief Clinical Officer
--
--

Umsatzaufteilung

Währung: USDAktualisiert: Tue, Jan 6
Währung: USDAktualisiert: Tue, Jan 6
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Nach RegionUSD
Name
Umsatz
Anteil
Hong Kong
14.27M
46.59%
Taiwan
7.09M
23.16%
The United States
5.51M
18.00%
United Kingdom
2.78M
9.08%
Rest of the world
972.00K
3.17%
Nach Geschäftsbereich
Nach Region
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.

Aktionärsstatistik

Aktualisiert: Wed, Feb 4
Aktualisiert: Wed, Feb 4
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Dennis (Lo Yuk Ming)
7.69%
Genetel Bioventures Ltd
4.90%
Lawrence (Tzang Chi Hung)
4.29%
Eastspring Investments (Singapore) Limited
3.42%
Aspex Management (HK) Limited
2.76%
Andere
76.94%
Aktionäre
Aktionäre
Anteil
Dennis (Lo Yuk Ming)
7.69%
Genetel Bioventures Ltd
4.90%
Lawrence (Tzang Chi Hung)
4.29%
Eastspring Investments (Singapore) Limited
3.42%
Aspex Management (HK) Limited
2.76%
Andere
76.94%
Aktionärstypen
Aktionäre
Anteil
Individual Investor
13.28%
Corporation
4.90%
Investment Advisor
3.82%
Hedge Fund
2.97%
Research Firm
2.63%
Investment Advisor/Hedge Fund
0.08%
Andere
72.32%

Institutionelle Beteiligung

Aktualisiert: Thu, Jan 1
Aktualisiert: Thu, Jan 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q4
24
1.19M
9.52%
-1.35M
2025Q3
23
1.16M
9.26%
-1.28M
2025Q2
30
3.73M
32.59%
-1.27M
2025Q1
31
3.72M
35.24%
-295.48K
2024Q4
35
3.71M
34.90%
-336.29K
2024Q3
37
3.69M
34.65%
-448.54K
2024Q2
38
3.76M
35.34%
-535.47K
2024Q1
88
5.56M
55.93%
+1.27M
2023Q4
94
4.17M
42.91%
+30.90K
2023Q3
99
4.01M
43.06%
+108.37K
Mehr Anzeigen

Aktionärsaktivitäten

Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Dennis (Lo Yuk Ming)
962.96K
7.69%
--
--
Apr 24, 2025
Genetel Bioventures Ltd
613.79K
4.9%
--
--
Sep 30, 2024
Lawrence (Tzang Chi Hung)
537.10K
4.29%
--
--
Apr 24, 2025
Eastspring Investments (Singapore) Limited
427.96K
3.42%
--
--
Sep 30, 2025
Aspex Management (HK) Limited
346.15K
2.76%
--
--
Sep 30, 2025
Nomura Securities Co., Ltd.
317.00K
2.53%
-4.83K
-1.50%
Sep 30, 2025
Chun (Lo Hoi)
162.62K
1.3%
--
--
Apr 24, 2025
Renaissance Technologies LLC
26.22K
0.21%
+26.22K
--
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
21.48K
0.17%
-1.26K
-5.56%
Sep 30, 2025
Stevens Capital Partners
17.38K
0.14%
--
--
Sep 30, 2025
Mehr Anzeigen

Verbundene ETFs

Aktualisiert: Sat, Dec 6
Aktualisiert: Sat, Dec 6
Name
Anteil
iShares Micro-Cap ETF
0.03%
iShares Micro-Cap ETF
Anteil0.03%

Dividende

In den vergangenen 5 Jahren wurden insgesamt 0.00 USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten

Aktien-Split

Datum
Ex-Dividendentag
Art
Verhältnis
Nov 01, 2023
Merger
15→1
Nov 01, 2023
Merger
15→1
Nov 01, 2023
Merger
15→1
Nov 01, 2023
Merger
15→1
Datum
Ex-Dividendentag
Art
Verhältnis
Nov 01, 2023
Merger
15→1
Nov 01, 2023
Merger
15→1
Nov 01, 2023
Merger
15→1
Nov 01, 2023
Merger
15→1
KeyAI